ArticleThe oncologist2019

Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors.

Bijun Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.